Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 04:10PM GMT
Release Date Price: $154.63 (+1.64%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good morning, everybody. It's my pleasure to welcome everybody back to the 41st Annual Cowen and Company Healthcare Conference. My name is Doug Schenkel. I am the life science and diagnostic tools analyst here at Cowen. It's my pleasure to welcome Helmy Eltoukhy, Co-Founder and Chief Executive Officer of Guardant, back to our conference, as well as Mike Bell, who is here for the first time as Chief Financial Officer of Guardant. Gentlemen, thank you both for taking the time and being here with us this morning.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

And thanks for having.

Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So for those who happen to not know Guardant and are maybe using this as an opportunity to just get up to speed on the story, Guardant is a molecular diagnostic company that provides comprehensive genomic profiling and other services to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot